

![]() |
Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial |
|
Authors | ![]() | |
Published in | BJOG: an International Journal of Obstetrics and Gynaecology. 2015, vol. 122, no. 1, p. 80-91 | |
Abstract | To evaluate the effectiveness of 200 mg of daily vaginal natural progesterone to prevent preterm birth in women with preterm labour. | |
Keywords | Administration, Intravaginal — Adult — Apgar Score — Birth Weight — Double-Blind Method — Female — Humans — Indomethacin/therapeutic use — Infant — Infant Mortality — Infant, Newborn — Intensive Care Units, Neonatal/utilization — Obstetric Labor, Premature/drug therapy — Pregnancy — Pregnancy Trimester, Second — Pregnancy Trimester, Third — Premature Birth/prevention & control — Progesterone/therapeutic use — Progestins/therapeutic use — Receptors, Oxytocin/antagonists & inhibitors — Tocolytic Agents/therapeutic use — Young Adult | |
Identifiers | PMID: 25209926 | |
Full text | ||
Structures | ||
Research group | Groupe Irion Olivier/Boulvain Michel (gynécologie et obstétrique) (272) | |
Citation (ISO format) | MARTINEZ DE TEJADA WEBER, Begona et al. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. In: BJOG: an International Journal of Obstetrics and Gynaecology, 2015, vol. 122, n° 1, p. 80-91. doi: 10.1111/1471-0528.13061 https://archive-ouverte.unige.ch/unige:89572 |